Seismic Therapeutic reels in $101m Series A
Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has secured $101 million in Series A funding.
Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has secured $101 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination